Navigation Links
North Shore-LIJ Health System Investing $400M to Connect Up to 7,000 Physicians, 13 Hospitals with Electronic Health Records System
Date:10/15/2009

s and possible therapeutic interventions that are considered best practices to help support the decision-making process. In addition, once elements of a care guide are selected, the system suggests a long-term plan for ongoing monitoring of the patient, based on their list of medical problems, as well as standard health care preventive maintenance based on the patient's age and gender.

"One of the fundamental flaws of our nation's health care system is underscored by the fact that 75 percent of our health care costs can be attributed to chronic preventable diseases affected by lifestyle choices such as smoking, poor eating habits and physical inactivity," said Lawrence G. Smith, MD, North Shore-LIJ's chief medical officer. "We need to change our focus from treating `sick' people to promoting an integrated approach to wellness, and a comprehensive electronic health record is a critical and necessary tool to achieving this goal."

Glen Tullman, CEO of Allscripts, noted that providing physicians with real-time care guidelines via the EHR increases the probability of achieving fundamental improvements in the quality of patient care. "Physicians are committed to providing the best possible care for their patients, but to deliver, they need just the right information at just the right time," said Mr. Tullman. "With this initiative, North Shore-LIJ is ensuring that physicians across the entire market area it serves not only have immediate access to the latest care guidelines, as well as access to patient information from every care setting, whether it's their own office, the emergency room or a clinic in another town. Connecting providers to each other and to the latest information is the key to helping our health care system do a better job of managing chronic diseases, providing preventative care, increasing the quality of the care provided and removing waste."

Full-time and affiliated physicians who use North Shore-LIJ's EHR will be able
'/>"/>

SOURCE North Shore-Long Island Jewish Health System; Allscripts
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Ascension Health, HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group announce the formation of The Healthcare Consortium
2. CDPHP Medicare Choices Expands Service Area Northward
3. Northridge Hospital Gets Over $10,000.00 in Donations From Local Dentists Office Grand Opening Charity Event
4. GlaxoSmithKline Applauds Compassion, Competence, Passion and Perseverance in North Carolinas Child Advocates
5. New Palliative Medicine Fellowship Created to Train Pacific Northwest Doctors in End-of-Life Care
6. Sleep Center at Baylor Dallas One of Select Centers in North Texas to Receive Accreditation
7. Ascension Health, HCA, North Shore-LIJ Health System, and Lightspeed Research -The Foresight Group announce the formation of The Healthcare Consortium
8. Local Nursing Home Leader Receives Life Care's Northwest Division President's Award
9. AdaptaVan, LLC Signs Two New Dealers: Company's Wheelchair Accessible Vans Now Available in North Carolina and Missouri
10. Northern California Cancer Center Finds Increased Risk of Most Common Form of Childhood Leukemia Associated With Residential Proximity to Agricultural Pesticides
11. President Clinton Hosts Special Session on Northern Ireland; Announces New Commitments Focused on Harnessing Innovation for Development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... September 02, 2014 Renal cell carcinoma (RCC) ... lining of the proximal convoluted tubule, a part of the ... from the blood to the urine. The condition is asymptomatic ... RCC are often in the advanced stages of the disease ... RCC often include blood in the urine, flank pain, a ...
(Date:9/1/2014)... London, UK (PRWEB) September 01, 2014 ... in developing more effective treatments for Alzheimer's disease ... disease. Uncertainties also exist regarding the diagnosis of ... hence, the lack of appropriate diagnostic tests. ... range of the greatest breakthroughs in the medicine ...
(Date:9/1/2014)... Dennis Thompson HealthDay Reporter ... experimental Ebola drug previously given to two American aid workers ... virus in laboratory tests, researchers report. The drug, ZMapp, ... if they didn,t get the medication until five days after ... Ebola who were days or even hours away from death, ...
(Date:9/1/2014)... September 01, 2014 BCC Research ( ... BLOOD-BRAIN BARRIER TECHNOLOGIES AND GLOBAL MARKETS , the global ... in 2013 and is expected to reach $38.7 million ... $471.5 million by 2019, which is equivalent to 64.9% ... The receptor-mediated transport (RMT) segment is forecasted to grow ...
(Date:9/1/2014)... September 01, 2014 Top10BestSEOHosting.com has ... many web host suppliers carefully, Top10BestSEOHosting.com is here ... the best web hosting suppliers in 2014. , ... clients with a top-of-the-line shared hosting plan. The ... easy-to-use platform that is affordable, accessible and powerful ...
Breaking Medicine News(10 mins):Health News:Renal Cell Carcinoma Market Analysis & Epidemiology Forecast to 2023 Says a New Report Available at MarketOptimizer.org 2Health News:Renal Cell Carcinoma Market Analysis & Epidemiology Forecast to 2023 Says a New Report Available at MarketOptimizer.org 3Health News:Renal Cell Carcinoma Market Analysis & Epidemiology Forecast to 2023 Says a New Report Available at MarketOptimizer.org 4Health News:Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com 2Health News:Early Stage Minimally Invasive Candidate AD Biomarkers Reviewed in New Study by Biopharm Reports Available at MarketPublishers.com 3Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 2Health News:Monkey Trial Supports Ebola Drug That May Have Helped 2 Stricken Americans 3Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 3Health News:Why Top10BestSEOHosting.com Calls Them Great Web Hosting Suppliers 2
... Recent surveys from,Centers for Disease Control and ... Epidemiology (APIC) have raised awareness of the,threat ... Staphylococcus aureus (MRSA). As the public learns,more ... simple steps,to protect themselves and loved ones ...
... NGSX ), a biopharmaceutical company focused on developing ... results for its third quarter of 2007 on Wednesday, ... call to review the results will begin at 4:30 ... will be hosted by Anthony DiTonno,President and Chief Executive ...
... overwhelming majority, 90 percent of Americans, claim a particular ... religiously diverse than ever before, which is why it ... clients beliefs stem from, says Dr. E. Thomas Dowd, ... much less religious than the general population, says Dowd. ...
... Commonwealth University researchers have discovered a new mechanism to ... clotting disorders, which could lead to novel therapies to ... in the body in areas such as the legs. ... a protein involved in coagulation, is inhibited, rendering blood ...
... - Request Provides CMS with New Scientific ... Ortho Biotech Products, L.P.,the company that ... that the Centers for Medicare and Medicaid ... (NCD) for,erythropoiesis-stimulating agents (ESAs). The company,s request ...
... the Washington,state man who,s spent more than a year walking ... to conclude his odyssey,today at the southernmost city in the ... Gregory set out from his home near the Canadian,border in ... job,with a beverage distributor to accommodate his plans. His trek ...
Cached Medicine News:Health News:Six Simple Steps to Protect Against and Stop the Spread of Superbugs 2Health News:NeurogesX to Report Third Quarter 2007 Financial Results on November 14, 2007 2Health News:NeurogesX to Report Third Quarter 2007 Financial Results on November 14, 2007 3Health News:Researchers identify molecules with interesting anti-clotting properties 2Health News:Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy 2Health News:Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy 3Health News:Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy 4Health News:Ortho Biotech to Submit Official Request for Reconsideration to CMS Regarding ESA Coverage Policy 5Health News:Cross-Country Walker to Finish His Journey for Cancer Research 2
(Date:8/29/2014)... 2014 According to the ... Services (Equipment, Reagent, Primer, Probe, Custom Oligos), End-User ... Gene Synthesis, NGS, DNA, RNAi) - Global Forecast ... Synthesis Market is expected to reach $1,712.1 Million ... at a CAGR of 9.8% from 2014 to ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Global Multiple Sclerosis Drugs Market 2014-2018" report to ... chronic, inflammatory medical condition that results in demyelination, axonal ... of an abnormal response by the immune system, which ... is a potentially debilitating disease in which the damage ...
(Date:8/29/2014)... British Columbia and MENLO PARK, ... DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the ... fiscal year-end financial statements.  The Company recently changed its ... facilitate an application to list its common stock on ... DelMar,s financial statements as filed with the ...
Breaking Medicine Technology:Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 2Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 3Oligonucleotide Synthesis Market Worth $1,712.1 Million by 2019 4Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 2Global Multiple Sclerosis Drugs Market 2014-2018: Key Vendors are Bayer, Biogen Idec, Merck Serono, Novartis and Teva Pharmaceutical 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... YORK , July 7 Reportlinker.com announces that a new market research ... , Stakeholder ... , , , ... , , ...
... July 7 Scientists have used a genetically reprogrammed herpes virus ... metastatic disease in mice – still an elusive goal when treating humans ... Gene Therapy. , ... Less than 30 percent of patients with metastatic cancer survive ...
Cached Medicine Technology:Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 2Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 3Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 4Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 5Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 6Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 7Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 8Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 9Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 10Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 11Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 12Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 13Stakeholder Opinions: Vaccines in emerging markets (Latin America) - Opportunities in Brazil, Mexico and Argentina 14Reprogrammed Herpes Virus Given Systemically Before Anti-vascular Drug Shrinks Distant Sarcomas 2Reprogrammed Herpes Virus Given Systemically Before Anti-vascular Drug Shrinks Distant Sarcomas 3Reprogrammed Herpes Virus Given Systemically Before Anti-vascular Drug Shrinks Distant Sarcomas 4
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Large type 1/1 (mm), opening width 13.0 mm and length 15 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 9 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 7 mm....
... The BacT/Alert 3D Select is ... automated microbial detection system that ... and mycobacteria culturing. This system ... management or laboratory information system ...
Medicine Products: